We’re excited about the products we have in the pipeline and the impact they will have on patients.

Product Indication Preclin Phase One Phase Two Phase Three
KIO-101 (Eyedrop) Ocular Manifestations of Rheumatoid Arthritis
KIO-201 (Eyedrop) PRK Surgical Recovery
KIO-301 (Intravitreal) Retinitis Pigmentosa
KIO-102 (Oral) Autoimmune Diseases
These therapeutics are still in development and are not yet approved for commercial use.